Search research articles
Contact Us
Filters
Showing results (11-20 of 30) with videos related to
Page
of 3
Sort By:
Anticancer Research
|
March 28, 2001
Urokinase-type plasminogen activator, plasminogen activator inhibitor type 1 and cathepsin D: analysis of their prognostic significance in squamous cell carcinoma of the head and neck
P Strojan, M Budihna, L Smid, et al.
Annals of Clinical Biochemistry
|
November 1, 1989
Salivary free testosterone in hirsutism
J Osredkar, I Vrhovec, N Jesenovec, et al.
Cancer Letters
|
September 29, 1998
Cathepsin D in tissue and serum of patients with squamous cell carcinoma of the head and neck
P Strojan, M Budihna, L Smid, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 16, 1998
Urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) in tissue and serum of head and neck squamous cell carcinoma patients
P Strojan, M Budihna, L Smid, et al.
Jugoslavenska Ginekologija I Opstetricija
|
January 1, 1982
[The response to gonadotropin-releasing hormone in hirsutism after treatment with cyproterone acetate]
A Kocijancic, M Pfeifer, J Prezelj, et al.
Neoplasma
|
May 1, 2001
Cathepsin B and L and stefin A and B levels as serum tumor markers in squamous cell carcinoma of the head and neck
P Strojan, M Budihna, L Smid, et al.
International Journal of Dermatology
|
September 6, 2000
Cathepsin D expression in early cutaneous malignant melanoma
I Bartenjev, Z Rudolf, B Stabuc, et al.
Neoplasma
|
April 13, 2002
Plasminogen activator inhibitor type 2: potential prognostic factor for endometrial carcinomas
M Osmak, D Babić, M Abramić, et al.
Anticancer Research
|
February 1, 2000
Drug resistant tumor cells have increased levels of tumor markers for invasion and metastasis
M Osmak, D Niksíc, A Brozović, et al.
Cancer Chemotherapy and Pharmacology
|
April 29, 1998
Effect of the multidrug resistance modulator valspodar on serum cortisol levels in rabbits
T Cufer, I Vrhovec, M Pfeifer, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 30) with videos related to
Sort By:
Page
of 3
Anticancer Research
|
March 28, 2001
Urokinase-type plasminogen activator, plasminogen activator inhibitor type 1 and cathepsin D: analysis of their prognostic significance in squamous cell carcinoma of the head and neck
P Strojan, M Budihna, L Smid, et al.
Annals of Clinical Biochemistry
|
November 1, 1989
Salivary free testosterone in hirsutism
J Osredkar, I Vrhovec, N Jesenovec, et al.
Cancer Letters
|
September 29, 1998
Cathepsin D in tissue and serum of patients with squamous cell carcinoma of the head and neck
P Strojan, M Budihna, L Smid, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 16, 1998
Urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) in tissue and serum of head and neck squamous cell carcinoma patients
P Strojan, M Budihna, L Smid, et al.
Jugoslavenska Ginekologija I Opstetricija
|
January 1, 1982
[The response to gonadotropin-releasing hormone in hirsutism after treatment with cyproterone acetate]
A Kocijancic, M Pfeifer, J Prezelj, et al.
Neoplasma
|
May 1, 2001
Cathepsin B and L and stefin A and B levels as serum tumor markers in squamous cell carcinoma of the head and neck
P Strojan, M Budihna, L Smid, et al.
International Journal of Dermatology
|
September 6, 2000
Cathepsin D expression in early cutaneous malignant melanoma
I Bartenjev, Z Rudolf, B Stabuc, et al.
Neoplasma
|
April 13, 2002
Plasminogen activator inhibitor type 2: potential prognostic factor for endometrial carcinomas
M Osmak, D Babić, M Abramić, et al.
Anticancer Research
|
February 1, 2000
Drug resistant tumor cells have increased levels of tumor markers for invasion and metastasis
M Osmak, D Niksíc, A Brozović, et al.
Cancer Chemotherapy and Pharmacology
|
April 29, 1998
Effect of the multidrug resistance modulator valspodar on serum cortisol levels in rabbits
T Cufer, I Vrhovec, M Pfeifer, et al.
Page
of 3